Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Co-Diagnostics, Inc. (CODX) is a Medical - Devices company based in US with a market capitalization of $9.5M. Revenue declined 84.1% year-over-year and free cash flow was negative at -$29.8M. This page tracks CODX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 132 employees · IPO Jul 12, 2017
Valuation
Valuation & price
$1.28as of May 17, 2026· -96.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.46
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$9.5M
Market cap
-84.1%
Revenue growth (YoY)
64.3%
Gross margin
-$29.8M
Free cash flow (USD)
-$10.6M
Net debt
Net cash position
31.6%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $-4.06)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingMay 28, 2026Filing
Securities Registration
- 8-K eventMay 21, 2026Filing
Securities Purchase Agreement
- 8-K eventMay 14, 2026Filing
Earnings Release
- Quarterly reportMay 14, 2026Filing
10-Q Filed
- FinancingMay 12, 2026Filing
Securities Registration
- 8-K eventMar 31, 2026Filing
Earnings Release
- Annual reportMar 31, 2026Filing
10-K Filed
Questions
Frequently asked questions
What is Co-Diagnostics, Inc.'s market cap?
Co-Diagnostics, Inc. (CODX) has a market capitalization of $9.5M.
What is CODX's P/E ratio?
A meaningful P/E ratio is not available for CODX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CODX's price-to-book (P/B) ratio?
CODX trades at 0.46 times book value per share.
When did Co-Diagnostics, Inc. last report earnings?
CODX last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying CODX stock?
SEC Form 4 filings show no open-market insider buys at Co-Diagnostics, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.